Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology

被引:253
作者
Porter, Kimberly R. [1 ]
McCarthy, Bridget J. [1 ]
Freels, Sally [1 ]
Kim, Yoonsang [1 ]
Davis, Faith G. [1 ]
机构
[1] Univ Illinois, Div Epidemiol & Biostat, Sch Publ Hlth, Chicago, IL 60612 USA
关键词
brain tumors; prevalence; United States; CANCER PREVALENCE; SURVIVAL RATES; EPIDEMIOLOGY; PATTERNS; CHILDREN;
D O I
10.1093/neuonc/nop066
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prevalence is the best indicator of cancer survivorship in the population, but few studies have focused on brain tumor prevalence because of previous data limitations. Hence, the full impact of primary brain tumors on the healthcare system in the United States is not completely described. The present study provides an estimate of the prevalence of disease in the United States, updating an earlier prevalence study. Incidence data for 2004 and survival data for 1985-2005 were obtained by the Central Brain Tumor Registry of the United States from selected regions, modeled under 2 different survival assumptions, to estimate prevalence rates for the year 2004 and projected estimates for 2010. The overall incidence rate for primary brain tumors was 18.1 per 100 000 person-years with 2-, 5-, 10-, and 20-year observed survival rates of 62%, 54%, 45%, and 30%, respectively. On the basis of the sum of nonmalignant and averaged malignant estimates, the overall prevalence rate of individuals with a brain tumor was estimated to be 209.0 per 100 000 in 2004 and 221.8 per 100 000 in 2010. The female prevalence rate (264.8 per 100 000) was higher than that in males (158.7 per 100 000). The averaged prevalence rate for malignant tumors (42.5 per 100 000) was lower than the prevalence for nonmalignant tumors (166.5 per 100 000). This study provides estimates of the 2004 (n = 612 770) and 2010 (n = 688 096) expected number of individuals living with primary brain tumor diagnoses in the United States, providing more current and robust estimates for aiding healthcare planning and patient advocacy for an aging US population.
引用
收藏
页码:520 / 527
页数:8
相关论文
共 27 条
[1]   THE PREVALENCE OF CANCER IN SWEDEN 1984 [J].
ADAMI, HO ;
GUNNARSSON, T ;
SPAREN, P ;
EKLUND, G .
ACTA ONCOLOGICA, 1989, 28 (04) :463-470
[2]  
[Anonymous], SURV EP END RES SEER
[3]  
[Anonymous], 2008, STAT REP PRIM BRAIN
[4]  
[Anonymous], SURVEILLANCE EPIDEMI
[5]  
[Anonymous], 2014, Fast Stats
[6]  
Arias Elizabeth, 2019, Natl Vital Stat Rep, V68, P1
[7]   Relative survival rates and patterns of diagnosis analyzed by time period for individuals with primary malignant brain tumor, 1973-1997 [J].
Barnholtz-Sloan, JS ;
Sloan, AE ;
Schwartz, AG .
JOURNAL OF NEUROSURGERY, 2003, 99 (03) :458-466
[8]   Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas - Data from the SEER program, 1973-2001 [J].
Claus, EB ;
Black, PM .
CANCER, 2006, 106 (06) :1358-1363
[9]   Cancer prevalence in France: Time trend, situation in 2002 and extrapolation to 2012 [J].
Colonna, Marc ;
Danzon, Arlette ;
Delafosse, Patricia ;
Mitton, Nicolas ;
Bara, Simona ;
Bouuier, Anne-Marie ;
Ganry, Olivier ;
Guizard, Anne-Valerie ;
Launoy, Guy ;
Molinie, Florence ;
Sauleau, Erik-Andr ;
Schvartz, Claire ;
Velten, Michel ;
Grosclaude, Pascale ;
Tretarre, Brigitte .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (01) :115-122
[10]  
Davis FG, 2001, NEURO-ONCOLOGY, V3, P152, DOI 10.1093/neuonc/3.3.152